In the pharmaceutical industry, the purity of Active Pharmaceutical Ingredients (APIs) is not just a benchmark. It is a critical requirement. Even the smallest trace of impurities can impact a drug’s safety, effectiveness, and overall quality. That is why getting it right from the start is so important.

At Coral Drugs, we take this responsibility seriously. Our manufacturing processes are built around strict control measures to limit impurities, including residual solvents and heavy metals. These are all potential contaminants that, if not managed carefully, could compromise the safety or performance of the final medication.

We follow rigorous analytical protocols and adhere to the highest global regulatory standards to ensure every batch meets or exceeds expectations. Compliance with current Good Manufacturing Practices (cGMP) and pharmacopeial standards is not just a checkbox for us. It is part of our core philosophy and a reflection of our commitment to quality.

When it comes to APIs, purity is not optional. It is essential. At Coral Drugs, we are proud to help ensure safer medicines by refusing to compromise on quality.

Interested in how Coral Drugs is raising the bar for pharmaceutical quality?
Follow us on LinkedIn for the latest news, insights, and industry updates.

‍